Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Aspirin |
Active Ingredient: | Aspirin 100mg |
Dosage Form: | Enteric coated tablet |
New Zealand Sponsor: | PSM Healthcare Limited trading as API Consumer Brands |
Manufacturer: | Medreich Limited, Bangalore, India |
Product: | Hyrimoz |
Active Ingredient: | Adalimumab 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Mylan Laboratories Limited, Bangalore, India |
Product: | Hyrimoz (Pen) |
Active Ingredient: | Adalimumab 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Mylan Laboratories Limited, Bangalore, India |
Product: | Octreotide Depot |
Active Ingredient: | Octreotide acetate 11.2mg equivalent to octreotide 10mg |
Dosage Form: | Powder for injection |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Pharmathen International SA, Rodopi, Greece |
Product: | Octreotide Depot |
Active Ingredient: | Octreotide acetate 22.4mg equivalent to octreotide 20mg |
Dosage Form: | Powder for injection |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Pharmathen International SA, Rodopi, Greece |
Product: | Octreotide Depot |
Active Ingredient: | Octreotide acetate 33.6mg equivalent to octreotide 30mg |
Dosage Form: | Powder for injection |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Pharmathen International SA, Rodopi, Greece |
Dated this 14th day of February 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).